First case of successful liver transplantation performed by a Moroccan team

Benkabbou, Amine; Awab, A.; Koraichi, Alae El; Souadka, Amine; Alilou, M.; Sbihi, L.; Moatassim, Nabil; Rhou, H.; Afifi, R.; Essaid, Almfadel; Belkouchi, A.

doi:10.1016/j.ajg.2016.02.001

Cited by 8 publications

(4 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hyperthermic Intraperitoneal Chemotherapy (HIPEC) was first performed in 2014 and is now available at one public center (National Institute of Oncology in Rabat) and two private clinics in Rabat and Casablanca [21]. Stem Cells Transplantation (both autologous and allogeneic) are available in the main cities (Rabat, Casablanca, Fes, and Marrakech).…”

Section: Medical Oncologymentioning

confidence: 99%

See 1 more Smart Citation

General Oncology Care in Morocco

Boutayeb

Majbar²

2022

Cancer in the Arab World

View full text Add to dashboard Cite

The current population of Morocco is estimated to be 37 million based on the projection of the United Nations data. The median age in the Moroccan population is young. Around 25% of the population is aged under 14 years. Morocco is currently in an epidemiological transition called “double burden,” with the coexistence of infectious and chronic diseases. The most frequent cancers in men are lung, prostate, bladder, colorectum, and lymphoma. Whereas, for women, the most frequent are breast, cervix, colorectum, thyroid, and ovary. The first Moroccan cancer plan (2010–2019) has given the priority to breast and cervix cancers. Concerning treatments, the classical chemotherapies, hormonal therapies, and the first generation of monoclonal antibodies (Trastuzumab, Rituximab, Bevacizumab, Cetuximab, etc.,) are widely available for the entire population. Two immunotherapies are available in Morocco: Pembrolizumab and Atezolizumab. However, their reimbursement is still conflictual. 3D and new irradiation techniques are available in the major cities. Advanced minimally invasive techniques are now routinely performed for colorectal, liver, gynecologic, thoracic, and urologic cancers. The first surgical robot was acquired by the university hospital in Fez in 2019.

show abstract

Section: Medical Oncologymentioning

confidence: 99%

“…There are also ongoing liver transplantation programs in university hospitals in Morocco. The first case of successful liver transplantation performed by a Moroccan team was reported in 2016 [21]. There is an ongoing program for living donor liver transplantation for liver cancers at the National Institute in Rabat.…”

Section: Surgerymentioning

confidence: 99%

General Oncology Care in Morocco

Boutayeb

Majbar²

2022

Cancer in the Arab World

View full text Add to dashboard Cite

show abstract

“…In Africa, liver transplantation (LT) programs exist in a few North African states and South Africa 14–16 . PLT is a small fraction of total LT volume in South Africa and Egypt 16,17 .…”

Section: Introductionmentioning

confidence: 99%

“…In Africa, liver transplantation (LT) programs exist in a few North African states and South Africa. [14][15][16] PLT is a small fraction of total LT volume in South Africa and Egypt. 16,17 Effectively, there are nearly 1 billion people across SSA without access to LT, leading to costly international travel for this service.…”

Section: Introductionmentioning

confidence: 99%

Examining need and capacity for the development of a pediatric liver transplantation program in Kenya

Muncner

Dell

Mwita³

et al. 2023

Pediatric Transplantation

View full text Add to dashboard Cite

Background: In Africa, pediatric liver transplantation (PLT) is currently only performed in Egypt and South Africa, leaving those who require treatment in Kenya to travel abroad. The aim of this study was to determine whether sufficient capacity and need exists in Kenya to establish a safe and sustainable PLT program. Methods:A descriptive analysis of the intensive care unit (ICU) beds, surgical workforce, current hepatobiliary volume, and estimated prevalence of pediatric liver disease (PLD) was conducted across 17 hospitals in Kenya between July and September 2020. Data were collected from medical superintendents, directors of surgical departments, or nominated proxies at Kenyan Level 5 and 6 hospitals via a web-based survey.Results: A total of 165 ICU beds were reported at 17 facilities, with 15 facilities reporting five or more beds. About 39% of general surgeons at responding hospitals performed hepatobiliary procedures, and 30% performed pediatric surgeries. Only 10% of surgeons had pediatric training. Over half (57%) of hospitals performed hepatobiliary procedures; at the maximum, 1-5 cases were performed per week including cholecystectomy to Kasai portoenterostomy and hepatectomy. Across 13 hospitals, there were an estimated 192-570 cases of PLD seen per month. The most common PLDs were hepatitis B, neonatal hepatitis, cirrhosis, and acute hepatic failure. Overall, two hospitals possessed the minimum workforce and resources to attempt PLT. Conclusions:In Kenya, ICU bed availability, pediatric surgical training, and hepatobiliary volume are limited. However, the high prevalence of PLD demonstrated a significant need for PLT across all Kenyan hospitals.

show abstract

Hepatocellular Carcinoma in Morocco

Cherradi¹

2021

Liver Cancer in the Middle East

View full text Add to dashboard Cite

First case of successful liver transplantation performed by a Moroccan team

Cited by 8 publications

References 6 publications

General Oncology Care in Morocco

General Oncology Care in Morocco

Examining need and capacity for the development of a pediatric liver transplantation program in Kenya

Hepatocellular Carcinoma in Morocco

Contact Info

Product

Resources

About